Donna L. LaVoie discusses four key industry areas that will experience downstream pressures in the wake of the COVID-19 crisis.
Donna L. LaVoie
Advertisement
Donna L. LaVoie is President & CEO of LaVoieHealthScience.
Articles by Donna L. LaVoie
Advertisement
Latest Updated Articles
COVID-19: Four Challenges for Issue Management TeamsPublished: April 17th 2020 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5